Jim Collins, the famed MIT professor and a godfather of the synthetic biology field, describes Felix Wong as one of the most ...

On Wednesday, Triveni Bio became the latest immunology and inflammation startup this year to announce a $100 million-plus ...

LoQus23 Therapeutics has secured £35 million ($43 million) in a Series A fundraise backed by the venture arm of Novartis to ...

GSK's ViiV Healthcare has suspended development of a Phase 2-stage HIV antiviral named VH3739937, a GSK spokesperson ...

Senators may be back in their districts gearing up for next month's elections, but that isn't stopping them from questioning ...

A New York federal judge has denied Amgen’s motion to dismiss a class action lawsuit alleging the company misled investors ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete ...

Months after announcing the failure of a mid-stage trial for its personalized neoantigen vaccine in cancer, Gritstone bio ...

Struggling healthcare giant CVS Health is considering breaking up the company, including separating its pharmacy and ...

Shattuck Labs is laying off 40% of its workforce and discontinuing its CD47 program in acute myeloid leukemia and higher-risk ...